ArticleeLife2020
Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
Chu Hsien Lim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this papercites it